Explore the microbiome’s profound influence on GLP-1, an essential satiety hormone for weight management and metabolic health. Join Fullscript’s Chief Medical Officer, Jeff Gladd, MD, and Medical Director, Alex Keller, ND, as they discuss the latest evidence supporting the use of a synbiotic formulation to support GLP-1 optimization and food cravings with Pendulum’s Chief Executive Officer, Colleen Cutcliffe, PhD.
Key points:
1. Address obesity prevalence, its complications, and highlight current management strategies.
2. Identify why the GLP-1 hormone is a key player in food cravings, satiety, and healthy weight management.
3. Discuss the mechanisms through which probiotic strains such as Akkermansia muciniphila and Clostridium butyricum induce downstream GLP-1 production.
4. Detail the science and evidence for the use of a synbiotic formulated to improve gut health and food cravings.
5. Introduce available protocols for GLP-1 optimization through the gut microbiome.